Literature DB >> 2185885

Factors regulating the activity of striatal neurons: new perspectives from in situ hybridization histochemistry.

B Morris1.   

Abstract

1. The basal ganglia contain a variety of putative peptide neurotransmitters. In situ hybridization allows changes in the levels of the mRNAs encoding these neuropeptides to be assessed at the cellular level of resolution. 2. Alterations in the activity of pathways within the basal ganglia of the rat produce distinct effects on the different neuropeptide mRNAs. 3. The evidence, where available, suggests that mRNA levels provide an index of peptide turnover. 4. This approach has consequently revealed much new information on the regulation of neuronal activity in the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185885     DOI: 10.1007/bf00733635

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  38 in total

1.  A reduction of the tone of 5-hydroxytryptamine neurons decreases utilization rates of striatal and hypothalamic enkephalins.

Authors:  I Mocchetti; O Giorgi; J P Schwartz; E Costa
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

2.  Differential expression of preproenkephalin and preprodynorphin mRNAs in striatal neurons: high levels of preproenkephalin expression depend on cerebral cortical afferents.

Authors:  G R Uhl; B Navia; J Douglas
Journal:  J Neurosci       Date:  1988-12       Impact factor: 6.167

3.  Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: contrasting effects of D1 and D2 antagonists.

Authors:  B J Morris; V Höllt; A Herz
Journal:  Neuroscience       Date:  1988-05       Impact factor: 3.590

4.  Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system.

Authors:  J Scheel-Krüger
Journal:  Acta Neurol Scand Suppl       Date:  1986

5.  Reduction of striatal dopaminergic neurotransmission elevates striatal proenkephalin mRNA.

Authors:  J A Angulo; L G Davis; B A Burkhart; G R Christoph
Journal:  Eur J Pharmacol       Date:  1986-11-04       Impact factor: 4.432

6.  Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.

Authors:  N Lindefors; E Brodin; U Tossman; J Segovia; U Ungerstedt
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

7.  Regulation of striatal prodynorphin mRNA levels by the raphe-striatal pathway.

Authors:  B J Morris; S Reimer; V Höllt; A Herz
Journal:  Brain Res       Date:  1988-08       Impact factor: 3.252

8.  Regulation of striatal enkephalin turnover in rats receiving antagonists of specific dopamine receptor subtypes.

Authors:  I Mocchetti; J R Naranjo; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1987-06       Impact factor: 4.030

9.  Morphine alters preproenkephalin gene expression.

Authors:  G R Uhl; J P Ryan; J P Schwartz
Journal:  Brain Res       Date:  1988-09-06       Impact factor: 3.252

10.  Depolarization regulates adrenal preproenkephalin mRNA.

Authors:  E F LaGamma; J D White; J E Adler; J E Krause; J F McKelvy; I B Black
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.